Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

The normal human prostate does not significantly affect blood DHT levels.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Shorter PSADT after prostate surgery is linked to higher risk of death.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Using finasteride with TIP extends time off period for prostate cancer patients.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Early hair loss may indicate future prostate issues.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Finasteride reduces prostate size and PSA levels in young patients.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.